Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.

Source:http://linkedlifedata.com/resource/pubmed/id/11245482

Cancer Res. 2001 Feb 15 61 4 1671-7

Download in:

View as

General Info

PMID
11245482